biojudiciary.org

		What is biojudiciary.org?
		Foreword
		Comments from the Bench
		Objectives

Patenting

History and Introduction to the U.S. Patent System General Patenting Process, PTO Office Overview General Patenting Process PTO Office Overview Disclosure Documents, Provisional and Nonprovisional Patent Applications Overview / Disclosure Document Provisional Patent Application Nonprovisional Patent Application Conception of Invention and Reduction to Practice Due Diligence True Invention Patent Life, Generic Drugs, and the Drug Approval Process Anti-trust Law Patenting Requirements Overview Sec. 101: Patentable Inventions and the Utility Requirement Overview Patentability Utility Pending Controversies Contemporary USPTO Utility Guidelines Sec. 102: Novelty, Loss of Right to Patent Overview Novelty Statutory Bar Specific Applicant Activities 35 U.S.C. Section 102 Conception Reduction to Practice Interference Practice Sec. 103: Non-Obvious Subject Matter Overview Overcoming Obviousness Rejections Sec. 112: Specification Overview 1^st Paragraph: Written Description, Enablement and Best Mode Second Paragraph—Subject Matter of a Claim Third, Fourth and Fifth Paragraphs—Independent, Dependent and Multiple Dependent Claims Sixth Paragraph—Means or Step Plus Function, Doctrine of Equivalence Overview Doctrine of Equivalence Inventorship Inventorship Generally Determining Inventorship Co- Inventorship Defensive Patent Enforcement Measures Inequitable Conduct Duty of Disclosure Infringement Sec. 271 Infringement Generally Direct Infringement Overview Literal Infringement Infringement Under the Doctrine of Equivalents Infringement of Means-Plus-Function Claims Indirect Infringement: An Overview of Induced & Contributory Infringement Infringement Under the Hatch-Waxman Act Infringement of a Product made Abroad by a Process Patented in the U.S. Selected Defenses Related Materials 35 U.S.C. Section 271 Markman Hearings The Effect of the Festo Decision